Guidelines International Network (GIN)
Powered by EBSCO

Guidelines International Network

3501 - 3510 of 3838 results found

Treatment of Anemia in Patients with Heart Disease: A Clinical Practice Guideline From the American College of Physicians

MeSH Terms
Hematinics (D27.505.954.502.543); Injections; Intravenous (E02.319.267.082.750); Iron (D01.552.544.412); Iron (D01.268.956.287); Iron (D01.268.556.412); Anemia; Iron-Deficiency (C15.378.071.196.300); Anemia; Iron-Deficiency (C18.452.565.100); Coronary Disease (C14.907.585.250); Coronary Disease (C14.280.647.250); Erythrocyte Transfusion (E02.095.135.140.275); Exercise Tolerance (G11.427.680.270); Heart Failure (C14.280.434)
Guideline Contact
Amir Qaseem ([email protected])
Publication Scope
management
Countries of Application
United States
Guideline Publication Status
Published
Languages
English
Authors
ACP (US)
Publication Year
2013

Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline

MeSH Terms

Adult

Bone Density Conservation Agents* / therapeutic use

Diphosphonates / therapeutic use

Humans

Hypercalcemia* / drug therapy

Hypercalcemia* / etiology

Neoplasms* / complications

Paraneoplastic Syndromes

Guideline Contact
Maureen Corrigan ([email protected])
Publication Scope
Evidence-Based Medicine
Countries of Application
International
Guideline Publication Status
Published
Languages
English
Authors
Endocrine Society
Willingness to Collaborate
Yes
Publication Year
2022

Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians

MeSH Terms
Vitamin D (D04.808.812.768); Women (M01.975); Osteoporosis (C05.116.198.579); Pharmacologic Actions (D27.505); Therapeutic Uses (D27.505.954); Alendronate (D02.705.429.500.100); Peptide Hormones (D06.472.699); Peptide Hormones (D12.644.548); Teriparatide (D06.472.699.590.850); Teriparatide (D12.644.548.587.850); Calcitonin (D06.472.699.150); Calcitonin (D12.644.400.095); Calcitonin (D12.644.548.150); Calcitonin (D12.776.641.650.095); Estrogen Replacement Therapy (E02.319.452.150); Selective Estrogen Receptor Modulators (D27.505.696.399.450.360.827); Selective Estrogen Receptor Modulators (D06.347.360.827); Raloxifene (D02.455.426.559.389.150.700.900.775); Osteoporosis; Postmenopausal (C05.116.198.579.610); Calcium (D01.268.552.100); Calcium (D01.552.539.288)
Guideline Contact
Amir Qaseem ([email protected])
Date for Review
2006-06-22
Publication Scope
prevention
treatment
Countries of Application
United States
Guideline Publication Status
Published
Languages
English
Authors
ACP (US)
Publication Year
2017

Treatment of medication overuse headache – guideline of the EFNS headache panel

MeSH Terms

Analgesics / adverse effects

Headache Disorders, Secondary / chemically induced

Headache Disorders, Secondary / therapy*

Humans

Guideline Contact
Prof. S. Evers, MD PhD, Department of Neurology, University of Münster, Albert-Schweitzer-Str. 33, 48129 Münster, Germany (tel.: +492518348196; fax: +492518348181; e-mail [email protected])
Publication Date
11 August 2011
Date of Last Evidence Search
January 2011
Methods Applied
Experts' recommendations
Publication Scope
Humans
Management
Management: Treatment
Headache / therapy
Management
Treatment, management
Countries of Application
Europe
Guideline Publication Status
Published
Languages
English
Authors
2
Willingness to Collaborate
Yes